Laserfiche WebLink
DocuSign Envelope ID: 666BF09F-322B-4680-BCBD-40579A7ED52C <br />5.2 MOUD/Medications. <br />5.2.1 Medications for opioid use disorder (MOUD) FDA approved buprenorphine, (this can include <br />long -acting injectable buprenorphine), methadone and naltrexone. <br />5.2.2 FDA approved medications for alcohol use disorder (MAUD). <br />5.2.3 Naloxone for jail and staff. <br />5.3 Program Supplies. <br />5.3.1 Technology: <br />5.3.1.1 Tablets. <br />5.3.1.2 Phones. <br />5.3.1.3 Security. <br />5.3.1.4 Internet/wi-fi enhancements to allow for telehealth. <br />5.3.1.5 Other supplies approved by HCA Contract Manager prior to purchase. <br />5.3.2 Program Staff Office Needs: <br />5.3.2.1 Desk. <br />5.3.2.2 Chair, <br />5.3.2.3 Computer. <br />5.3.2.4 Phone. <br />5.4 Release and Reentry. <br />5.4.1 Transportation for program participants upon release to first appointment, pick up <br />prescription, safe place, etc. <br />5.4.2 Release kit items such as: <br />5.4.2.1 Naloxone. <br />5.4.2.2 Gift cards. <br />5.4.2.3 <br />Clothing, shoes. <br />5.4.2.4 <br />Personal hygiene items. <br />5.4.2.5 <br />Phones. <br />Washington State Page 9 of 10 MOUD in Jails Services <br />Health Care Authority HCA Contract No. K5885-3 <br />Schedule A-3 <br />